
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>102-272</title>
    </head>

    <body>
        <h1>
        <a href="./102_271.html" rel="external" title="prev">≪</a>
        102-272
        <a href="./102_273.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p>30歳女性。排尿痛、頻尿の症状があり、近医を受診した。急性単純性膀胱炎と診断され、以下の処方箋を薬局に持参した。薬歴を確認すると、同一の医師より消化性潰瘍治療のためスクラルファート細粒90%の処方があり、毎食後に服用中であった。</p>
<p><img alt="" class="alignnone size-full wp-image-3482" height="68.6" loading="lazy" sizes="(max-width: 563px) 100vw, 563px" src="data:;base64,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" width="394.09999999999997"/></p>
<h4>問272</h4>
<p>医師への疑義照会時に提案する内容として適切なのはどれか。2つ選べ。</p>
<ol><li>シプロフロキサシンをノルフロキサシンに変更する。</li><li>シプロフロキサシンをセフジニルに変更する。</li><li>シプロフロキサシンを服用後、2時間以上あけてスクラルファートを服用するように用法を変更する。</li><li>シプロフロキサシンを増量する。</li><li>スクラルファートをアルギン酸ナトリウムに変更する。</li></ol>
<h4>問273</h4>
<p>前問での提案の理由となるシプロフロキサシンとスクラルファートの相互作用の機序として、最も適切なのはどれか。1つ選べ。</p>
<ol><li>胃内pHの変化に伴う溶解性の低下</li><li>消化管内における難溶性キレートの形成</li><li>消化管吸収に関わるトランスポーターの阻害</li><li>血漿タンパク結合の阻害</li><li>腎尿細管における再吸収の阻害</li></ol>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            問272：3, 5問273：2
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <h4>問272</h4>
<p>問273 とまとめて解説します。</p>
<h4>問273</h4>
<p>スクラルファートは、ショ糖硫酸エステルアルミニウム塩です。胃粘膜保護薬です。</p>
<p>シプロフロキサシンは、ニューキノロン系の抗菌薬です。DNAジャイレース阻害薬です。ニューキノロン＋金属イオン含有製剤　ではキレート形成により吸収低下が見られます。同時に使用する場合は時間をある程度開けての服用で相互作用を軽減することができます。</p>
<p>問272 の選択肢 1 ですが<br/>変更したものもニューキノロンなので、やはり相互作用により吸収低下してしまいます。</p>
<p>選択肢 2 ですが<br/>セフジニルはセフェム系抗生物質です。これも、ニューキノロンと同様に金属とのキレートを形成する相互作用による吸収低下が知られており不適切であると考えられます。</p>
<p>選択肢 3 は、正しい記述です。</p>
<p>選択肢 4 ですが<br/>増量しても吸収率が低いのではあまり意味がなく、また、吸収されずに消化管に到達する薬の量が多くなることから、副作用として腸内細菌への悪影響のおそれがあり不適切であると考えられます。</p>
<p>選択肢 5 は、正しい記述です。</p>
<p>以上より、問272 の正解は 3,5 です。<br/>問273 の正解は 2 です。</p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    